About Sulis Therapeutics
Sulis Therapeutics is a Healthcare company based in Aarhus (Denmark) founded in 2024. It develops innovative therapeutic technologies for systemic sclerosis and other inflammatory diseases. It operates on a B2B model. Its focus areas include Biotechnology, Therapeutics and Inflammatory Diseases.
Company details
Sulis Therapeutics, based in Aarhus, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and inflammatory diseases. Develops innovative therapeutic technologies for systemic sclerosis and other inflammatory diseases. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Aarhus, Denmark
- SectorsHealthcare
- Website sulistx.com
- Social LinkedIn
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sulis Therapeutics
Sulis Therapeutics was founded in 2024.
Sulis Therapeutics is headquartered in Aarhus, Denmark.
Sulis Therapeutics, based in Aarhus, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and inflammatory diseases. Develops innovative therapeutic technologies for systemic sclerosis and other inflammatory diseases. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.